Maternal Buprenorphine-naloxone Treatment During the Perinatal Period: Fetal and Infant Effects
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2018
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Methadone
- Indications Opioid abuse
- Focus Therapeutic Use
- 29 May 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Apr 2018 to 1 Jun 2018.
- 29 May 2018 Status changed from not yet recruiting to recruiting.
- 09 Mar 2018 Planned initiation date changed from 1 Jan 2018 to 1 Apr 2018.